Brief: Orgenesis And Johns Hopkins University Collaborate For Creation Of The Maryland Center For Cell Therapy Manufacturing
18/01/2022 12:37
Jan 18 (Reuters) - Johns Hopkins University JOHNO.UL :
* ORGENESIS AND JOHNS HOPKINS UNIVERSITY EXPAND POCARE IN
MARYLAND
THROUGH CREATION OF THE MARYLAND CENTER FOR CELL THERAPY
MANUFACTURING
Source text for Eikon: ID:nGNX5lG8S1
Further company coverage: JOHNO.UL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules